AI identifies new high-risk subtype in endometrial cancer

FHS
June 28, 2024
9:38 am

An AI tool to classify histopathological images and differentiate between endometrial cancer subtypes.

Upfront Ezetimibe in ACS; New Watchman LAA Occluder OK’d; Low-Cost FH Genotyping

Compared with statins alone, upfront dual therapy with a statin and ezetimibe (Zetia) was associated with better survival in acute coronary syndrome, a Polish registry

September 13, 2023

Transgender women’s higher risk for HIV is influenced by discrimination, CDC finds

Transgender women, in particular those belonging to marginalized racial and ethnic groups, have disproportionately high rates of HIV. Yet so far, no standardized surveillance system

January 25, 2024

Why Healthcare AI Must Maintain Multiple Layers of Specificity

Dr. Tamir Wolf, co-founder and CEO of Theator The recent explosion of generative AI has pushed public discourse to a palpable tipping point. Nearly overnight,

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.